Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

15 Voluntary ex ante Transparency (VEAT) Notice

Enzyme Indicator Technology and Equipment

  • First published: 08 November 2022
  • Last modified: 08 November 2022
  • Record interest

     

  • This file may not be fully accessible.

  •  

Contents

Summary

OCID:
ocds-kuma6s-126372
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
08 November 2022
Deadline date:
-
Notice type:
15 Voluntary ex ante Transparency (VEAT) Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS Wales Shared Services Partnership (NWSSP) is seeking to develop a new approach towards the cleaning of Aseptic Suites and their Clean Rooms. NWSSP has identified the requirement to purchase Enzyme Indicator technology to enable the measurement of the “Kill Rate” within an Aseptic Suite that is also compatible using iHP gassing methods. CPV: 24965000, 24965000.

Full notice text

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

NWSSP

4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw

Cardiff

SA62 2PZ

UK

Contact person: Samantha Pennington

E-mail: Samantha.Pennington@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Enzyme Indicator Technology and Equipment

II.1.2) Main CPV code

24965000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

NHS Wales Shared Services Partnership (NWSSP) is seeking to develop a new approach towards the cleaning of Aseptic Suites and their Clean Rooms.

NWSSP has identified the requirement to purchase Enzyme Indicator technology to enable the measurement of the “Kill Rate” within an Aseptic Suite that is also compatible using iHP gassing methods.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 320 000.00  GBP

II.2) Description

II.2.2) Additional CPV code(s)

24965000

II.2.3) Place of performance

NUTS code:

UKL2


Main site or place of performance:

Pharmacy CIVAS @ IP5

NHS Wales Shared Services Partnership

Unit 5 Imperial Park

Celtic Way

Newport NP10 8BE

United Kingdom

II.2.4) Description of the procurement

Enzyme Indicators contain an enzyme that has a high tolerance to high temperatures and oxidising agents, and after a gassing cycle has been conducted, the rate at which the enzyme has denatured is measured, thus proving a measure of the Kill Rate, and therefore the cleanliness of the Aseptic Suite.

Enzyme Indicators will be used as part of a new gassing method for cleaning the Aseptic Medicines Manufacturing suite at the CIVAS@IP5 facility. Enzyme Indicators are required to verify that the gassing cycle, using ionised Hydrogen Peroxide, has been successful in killing microorganisms.

In addition, Enzyme Indicators provide a result within minutes, resulting in far less downtime for the Aseptic Suite. Furthermore, Enzyme Indicators provide a rate of denaturing on a logarithmic scale, allowing for Quality Assurance levels to be set for each grade of Clean Room.

II.2.5) Award criteria

Criteria below:

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

Protak Scientific owns the intellectual property for this technology

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Section V: Award of contract/concession

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

08/11/2022

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Protak Scientific Limited

Luminox House, 48 Holmethorpe Avenue

Redhill

RH12NL

UK

NUTS: UKL2

The contractor is an SME: No

V.2.4) Information on value of the concession and main financing terms (excluding VAT)

Total value of the concession/lot: 320 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=126372.

(WA Ref:126372)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

08/11/2022

Coding

Commodity categories

ID Title Parent category
24965000 Enzymes Various chemical products

Delivery locations

ID Description
1022 Cardiff and Vale of Glamorgan
1020 East Wales
1023 Flintshire and Wrexham
1021 Monmouthshire and Newport
1024 Powys

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
Samantha.Pennington@wales.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
21/11/2022 12:08
Enzyme Indicator Technology and Equipment - Additional Clarification to the Requirements
NHS Wales Shared Services Partnership (NWSSP) is seeking to develop a new approach towards the cleaning of Aseptic Suites and their Clean Rooms. Currently the use of sporicidal wet wipes containing Hydrogen Peroxide is implemented, which presents various Health and Safety risks to our staff, as well as an environmental impact associated with the disposal of many wet wipes per year. NWSSP is now seeking to utilise Ionised Hydrogen Peroxide (iHP) to sterilise the Clean Rooms, as this avoids the Health and Safety risks associated with wet wipes, is a quicker overall process, and enables our staff to work on other activities whilst the gassing cycle occurs. iHP works by damaging organism through the oxidation of cellular proteins, carbohydrates, and lipids.

The current method of validating how clean a Clean Room is uses SDA & TSA Contact and Settle Plates, which is incompatible with using iHP to identify if the room is sufficiently clean – Contact & Settle Plates measure a “Living Rate” on a surface after cleaning, whereas iHP requires a measure of the “Kill Rate” with indicators exposed to the iHP gas during cleaning. To note however, Contact & Settle Plates will still be required as part of environmental monitoring and other Quality Assurance activities).

• The procured solution will be used in Clean Rooms of Grades B, C, and D (as defined within EU GMP Annex 1 – Basic Elements Clean Room Classification)
• The procured solution will be used to verify that a gassing cycle of iHP has been successful in sterilising the exposed rooms

1. The solution Must be compatible with Ionised Hydrogen Peroxide gassing technology
2. The solution Must identify the “Kill Rate” after a room has undergone an Ionised Hydrogen Peroxide gassing cycle
a. “Kill Rate” quantifies the rate at which organisms (including viruses, bacteria, and fungi) within the clean room have been destroyed
3. The solution Must include both the material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material, which arises from the iHP gas – i.e. the results on how successful the iHP gassing cycle has been
4. The solution Must be able to provide results on the Kill Rate within 1 hour of completing the iHP gassing cycle
5. The solution Must indicate whether or not the iHP gassing cycle has been successful – i.e. at minimum, a pass/fail result
6. The solution Should provide results of gassing success in a non-binary manner. I.e. the solution Should indicate how successful the gassing cycle has been in some form of scale, resulting in the ability for the Authority to place Quality Assurance levels to be set for each Clean Room within the Aseptic Suite.
7. All components of the solution (including material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material) Must be operated within the Authority’s premises, and by the Authority’s staff. For the avoidance of doubt, the solution Must not require samples being sent outside of the Authority’s premises for analysis.
8. The solution Must result in the Authority owning equipment. I.e. the core solution (material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material) Must not be provided as a Service, though training and ongoing support is expected to be delivered as a Service.
9. The solution Must have no specialist storage requirements, where refrigeration is deemed to be non-specialist
10. The solution Must require minimal, non-specialist, training to use – i.e. anybody with a basic level of training will be able to use the solution



21/11/2022 12:22
Enzyme Indicator Technology and Equipment - Additional Clarification to the Requirements
NHS Wales Shared Services Partnership (NWSSP) is seeking to develop a new approach towards the cleaning of Aseptic Suites and their Clean Rooms. Currently the use of sporicidal wet wipes containing Hydrogen Peroxide is implemented, which presents various Health and Safety risks to our staff, as well as an environmental impact associated with the disposal of many wet wipes per year. NWSSP is now seeking to utilise Ionised Hydrogen Peroxide (iHP) to sterilise the Clean Rooms, as this avoids the Health and Safety risks associated with wet wipes, is a quicker overall process, and enables our staff to work on other activities whilst the gassing cycle occurs. iHP works by damaging organism through the oxidation of cellular proteins, carbohydrates, and lipids.

The current method of validating how clean a Clean Room is uses SDA & TSA Contact and Settle Plates, which is incompatible with using iHP to identify if the room is sufficiently clean – Contact & Settle Plates measure a “Living Rate” on a surface after cleaning, whereas iHP requires a measure of the “Kill Rate” with indicators exposed to the iHP gas during cleaning. To note however, Contact & Settle Plates will still be required as part of environmental monitoring and other Quality Assurance activities).

-The procured solution will be used in Clean Rooms of Grades B, C, and D (as defined within EU GMP Annex 1 – Basic Elements Clean Room Classification)
- The procured solution will be used to verify that a gassing cycle of iHP has been successful in sterilising the exposed rooms

The solution Must be compatible with Ionised Hydrogen Peroxide gassing technology
The solution Must identify the “Kill Rate” after a room has undergone an Ionised Hydrogen Peroxide gassing cycle
a. “Kill Rate” quantifies the rate at which organisms (including viruses, bacteria, and fungi) within the clean room have been destroyed
The solution Must include both the material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material, which arises from the iHP gas – i.e., the results on how successful the iHP gassing cycle has been

The solution Must be able to provide results on the Kill Rate within 1 hour of completing the iHP gassing cycle
The solution Must indicate whether or not the iHP gassing cycle has been successful – i.e., at minimum, a pass/fail result
The solution Should provide results of gassing success in a non-binary manner. I.e., the solution Should indicate how successful the gassing cycle has been in some form of scale, resulting in the ability for the Authority to place Quality Assurance levels to be set for each Clean Room within the Aseptic Suite.
All components of the solution (including material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material) Must be operated within the Authority’s premises, and by the Authority’s staff. For the avoidance of doubt, the solution Must not require samples being sent outside of the Authority’s premises for analysis.
The solution Must result in the Authority owning equipment. I.e., the core solution (material that will be exposed to iHP gas, as well as supporting product(s) to measure the Kill Rate of the material) Must not be provided as a Service, though training and ongoing support is expected to be delivered as a Service.
The solution Must have no specialist storage requirements, where refrigeration is deemed to be non-specialist
The solution Must require minimal, non-specialist, training to use – i.e., anybody with a basic level of training will be able to use the solution



0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.